Effectiveness of two formulations of oral olanzapine in patients with schizophrenia or bipolar disorder in a natural setting: results from a 1-year European observational study-Reference-Cited by-同舟云学术

Effectiveness of two formulations of oral olanzapine in patients with schizophrenia or bipolar disorder in a natural setting: results from a 1-year European observational study

Published:2012-03-31 Issue:3 Volume:27 Page:284-294
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Kraemer Susanne¹,Chartier Florence²,Augendre-Ferrante Béatrice²,Psarra Vassiliki³,D'yachkova Yulia⁴,Beselin Anke¹,Rouillon Fréderic⁵

Affiliation:

1. Lilly Deutschland GmbH; Bad Homburg; Germany

2. Eli Lilly and Company; Suresnes; France

3. Psychiatric Hospital of Attiki ‘Dafni’; Haidari; Greece

4. Eli Lilly GmbH; Vienna; Austria

5. CMME Hôpital St Anne; Paris; France

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hup.2224/fullpdf

Reference35 articles.

1. Awareness of illness in schizophrenia;Amador;Schizophr Bull,1991

2. Poor insight in schizophrenia;Amador;Psychiatr Q,1993

3. Awareness of illness in schizophrenia and schizoaffective and mood disorders;Amador;Arch Gen Psychiatry,1994

4. Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients;Arranz;Hum Psychopharmacol,2007

5. Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study;Bitter;World J Biol Psychiatry,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peculiarities of personalized selection of antipsychotic drugs for schizophrenia treatment;Medicni perspektivi;2024-04-01

2. Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands;Journal of Medical Economics;2017-08-14

3. Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder;Patient Preference and Adherence;2017-06

4. P.3.d.060 Comparative clinical outcomes of orodispersable versus standard oral olanzapine tablets in non-adherent patients with schizophrenia or bipolar disorder;European Neuropsychopharmacology;2015-09

5. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study;BMC Psychiatry;2015-08-05